Development and Validation of Vitiligo-Specific-Belief About Therapy Questionnaire (BTQ-Vitiligo)

IF 2.6 3区 医学 Q2 CELL BIOLOGY
Sree Yazhini Ramar, Sivaranjini Ramassamy, Malathi Munisamy, Subitha Lakshminarayanan, Ruben Raj, Raja Rajeswari Thanmalagan, Remya Raj
{"title":"Development and Validation of Vitiligo-Specific-Belief About Therapy Questionnaire (BTQ-Vitiligo)","authors":"Sree Yazhini Ramar,&nbsp;Sivaranjini Ramassamy,&nbsp;Malathi Munisamy,&nbsp;Subitha Lakshminarayanan,&nbsp;Ruben Raj,&nbsp;Raja Rajeswari Thanmalagan,&nbsp;Remya Raj","doi":"10.1111/pcmr.70049","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>There is a need to capture therapy-related beliefs held by patients with conditions like vitiligo that have complex treatment regimens. Concerns about adverse effects and uncertainty about response to the prescribed treatment can impact adherence and the perceived treatment burden. This study aims to develop and validate a questionnaire on beliefs about therapy in patients with vitiligo. It is a cross-sectional study. A vitiligo-specific item pool was developed through literature review, in-depth interviews with patients with vitiligo (<i>n</i> = 10), and expert surveys (<i>n</i> = 8). The instrument was studied on 140 patients for psychometric properties using the Vitiligo Treatment Impact score (VITs) and Medication Adherence Rating Scale-5 (MARS-5); self-reported severity using PtGA (Patient Global Assessment) and Response VASI (Vitiligo Area Scoring Index). Exploratory factor analysis demonstrated a six-factor structure with 21 items. Discriminant validity was evidenced by correlation between response VASI and questionnaire subscales (<i>r</i> = −0.538). Correlation with VITs (<i>r</i> = −0.610), MARS-5 (<i>r</i> = 0.453), and PtGA (<i>r</i> = 0.486) demonstrated construct and criterion validity, respectively. BTQ-vitiligo demonstrated test–retest reliability (<i>r</i> = 0.779) during the follow-up visit. BTQ-vitiligo is a validated instrument that helps clinicians understand patients' perspectives about therapy and tailor it accordingly to ensure adherence and further response to therapy. We developed and validated a BTQ-vitiligo, a valuable tool for capturing therapy-related beliefs in vitiligo, a complex dermatological disease with medication challenges. Although several patient-reported outcome measures (PROMs) have been developed to assess various aspects of vitiligo, none exist to capture patients' beliefs about therapy, which is a key determinant of the perceived burden of treatment. Our questionnaire identifies general and specific medication beliefs across six domains, with 21 items included under it.</p>\n </div>","PeriodicalId":219,"journal":{"name":"Pigment Cell & Melanoma Research","volume":"38 5","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pigment Cell & Melanoma Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/pcmr.70049","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

There is a need to capture therapy-related beliefs held by patients with conditions like vitiligo that have complex treatment regimens. Concerns about adverse effects and uncertainty about response to the prescribed treatment can impact adherence and the perceived treatment burden. This study aims to develop and validate a questionnaire on beliefs about therapy in patients with vitiligo. It is a cross-sectional study. A vitiligo-specific item pool was developed through literature review, in-depth interviews with patients with vitiligo (n = 10), and expert surveys (n = 8). The instrument was studied on 140 patients for psychometric properties using the Vitiligo Treatment Impact score (VITs) and Medication Adherence Rating Scale-5 (MARS-5); self-reported severity using PtGA (Patient Global Assessment) and Response VASI (Vitiligo Area Scoring Index). Exploratory factor analysis demonstrated a six-factor structure with 21 items. Discriminant validity was evidenced by correlation between response VASI and questionnaire subscales (r = −0.538). Correlation with VITs (r = −0.610), MARS-5 (r = 0.453), and PtGA (r = 0.486) demonstrated construct and criterion validity, respectively. BTQ-vitiligo demonstrated test–retest reliability (r = 0.779) during the follow-up visit. BTQ-vitiligo is a validated instrument that helps clinicians understand patients' perspectives about therapy and tailor it accordingly to ensure adherence and further response to therapy. We developed and validated a BTQ-vitiligo, a valuable tool for capturing therapy-related beliefs in vitiligo, a complex dermatological disease with medication challenges. Although several patient-reported outcome measures (PROMs) have been developed to assess various aspects of vitiligo, none exist to capture patients' beliefs about therapy, which is a key determinant of the perceived burden of treatment. Our questionnaire identifies general and specific medication beliefs across six domains, with 21 items included under it.

Abstract Image

白癜风治疗特异性信念问卷(btq -白癜风)的编制与验证
有必要了解白癜风等有复杂治疗方案的患者所持有的与治疗相关的信念。对不良反应的担忧和对规定治疗反应的不确定性会影响依从性和治疗负担。本研究旨在开发并验证白癜风患者治疗信念问卷。这是一项横断面研究。通过文献综述、对白癜风患者的深度访谈(n = 10)和专家调查(n = 8),建立白癜风特异性项目库。采用白癜风治疗影响评分(VITs)和药物依从性评定量表-5 (MARS-5)对140例患者的心理测量特性进行了研究;使用PtGA(患者整体评估)和VASI(白癜风区域评分指数)自我报告的严重程度。探索性因子分析显示具有6个因子结构,共21个项目。反应VASI与问卷各分量表的相关性(r = - 0.538)证明了判别效度。与VITs (r = - 0.610)、MARS-5 (r = 0.453)和PtGA (r = 0.486)的相关性分别证明了结构效度和标准效度。btq -白癜风在随访期间具有重测信度(r = 0.779)。btq -白癜风是一种经过验证的工具,可帮助临床医生了解患者对治疗的看法,并相应地进行调整,以确保依从性和对治疗的进一步反应。我们开发并验证了btq -白癜风,这是一个有价值的工具,用于捕获白癜风治疗相关的信念,白癜风是一种复杂的皮肤疾病,具有药物挑战。虽然已经开发了一些患者报告的结果测量(PROMs)来评估白癜风的各个方面,但没有一个能够捕捉患者对治疗的信念,这是感知治疗负担的关键决定因素。我们的调查问卷确定了六个领域的一般和特定的药物信念,其中包括21个项目。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pigment Cell & Melanoma Research
Pigment Cell & Melanoma Research 医学-皮肤病学
CiteScore
8.90
自引率
2.30%
发文量
54
审稿时长
6-12 weeks
期刊介绍: Pigment Cell & Melanoma Researchpublishes manuscripts on all aspects of pigment cells including development, cell and molecular biology, genetics, diseases of pigment cells including melanoma. Papers that provide insights into the causes and progression of melanoma including the process of metastasis and invasion, proliferation, senescence, apoptosis or gene regulation are especially welcome, as are papers that use the melanocyte system to answer questions of general biological relevance. Papers that are purely descriptive or make only minor advances to our knowledge of pigment cells or melanoma in particular are not suitable for this journal. Keywords Pigment Cell & Melanoma Research, cell biology, melatonin, biochemistry, chemistry, comparative biology, dermatology, developmental biology, genetics, hormones, intracellular signalling, melanoma, molecular biology, ocular and extracutaneous melanin, pharmacology, photobiology, physics, pigmentary disorders
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信